Literature DB >> 10931380

A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro.

S E Stehle1, R A Rogers, A G Harmsen, R A Ezekowitz.   

Abstract

Pneumocystis carinii is an opportunistic pathogen that causes pneumonia in immunocompromised hosts. In the normal host, P. carinii is susceptible to an array of first line host defense mechanisms that are operative in the lung. Alveolar macrophages play a central role in the clearance of inhaled organisms. The macrophage mannose receptor (MR) appears to be sufficient for P. carinii phagocytosis. In individuals infected with the human immunodeficiency virus, MR expression on alveolar macrophages and P. carinii phagocytosis are decreased, however, Fc-receptor mediated phagocytosis remains intact. In this study, we demonstrate that a recombinant soluble MR immunoadhesin, consisting of the essential carbohydrate binding MR ectodomain and the Fc-region of human immunoglobulin (Ig)G1, binds P. carinii and leads to an 8.2-fold increased uptake of P. carinii by phagocytic cells. Our results suggest that the soluble MR immunoadhesin may have therapeutic potential in the treatment of P. carinii infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931380     DOI: 10.1046/j.1365-3083.2000.00755.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Epithelial cell surface sites involved in the polyvalent adherence of Porphyromonas gingivalis: a convincing role for neuraminic acid and glucuronic acid.

Authors:  G Agnani; S Tricot-Doleux; S Houalet; M Bonnaure-Mallet
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.

Authors:  Mark E Lasbury; Xing Tang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.

Authors:  Cristina Gil-Lamaignere; Emmanuel Roilides; Caron A Lyman; Maria Simitsopoulou; Theodouli Stergiopoulou; Avgi Maloukou; Thomas J Walsh
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

4.  Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.

Authors:  Mark E Lasbury; Peimao Lin; Dennis Tschang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

5.  DEC205 mediates local and systemic immune responses to Helicobacter pylori infection in humans.

Authors:  Masahide Kita; Kenji Yokota; Chihiro Kageyama; Susumu Take; Kazuyoshi Goto; Yoshiro Kawahara; Osamu Matsushita; Hiroyuki Okada
Journal:  Oncotarget       Date:  2018-02-26

Review 6.  The Interaction of Human Pathogenic Fungi With C-Type Lectin Receptors.

Authors:  Surabhi Goyal; Juan Camilo Castrillón-Betancur; Esther Klaile; Hortense Slevogt
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 7.  Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Pneumocystis Innate Immunity.

Authors:  Theodore J Kottom; Eva M Carmona; Andrew H Limper
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

8.  N-glycolyl GM1 ganglioside as a receptor for simian virus 40.

Authors:  Maria A Campanero-Rhodes; Alicia Smith; Wengang Chai; Sandro Sonnino; Laura Mauri; Robert A Childs; Yibing Zhang; Helge Ewers; Ari Helenius; Anne Imberty; Ten Feizi
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.

Authors:  Chad Steele; Luis Marrero; Steve Swain; Allen G Harmsen; Mingquan Zheng; Gordon D Brown; Siamon Gordon; Judd E Shellito; Jay K Kolls
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.